Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells

M. Visweswaran; Frank Arfuso; Sudha  Warrier; Arunasalam Dharmarajan

doi:10.1002/stem.3101

Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells

M. Visweswaran
, Frank Arfuso
, Sudha Warrier
, Arunasalam Dharmarajan

Research output: Contribution to journal › Review article › peer-review

88 Citations (Scopus)

Abstract

Emerging evidence in cancer metabolomics has identified reprogrammed metabolic pathways to be a major hallmark of cancer, among which deregulated lipid metabolism is a prominent field receiving increasing attention. Cancer stem cells (CSCs) comprise

Original language	English
Pages (from-to)	6-14
Number of pages	9
Journal	Stem Cells
Volume	38
Issue number	1
DOIs	https://doi.org/10.1002/stem.3101
Publication status	Published - 1 Jan 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/stem.3101

Cite this

@article{786ef3fb83474fc49d2a9247ac4365ef,

title = "Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells",

abstract = "Emerging evidence in cancer metabolomics has identified reprogrammed metabolic pathways to be a major hallmark of cancer, among which deregulated lipid metabolism is a prominent field receiving increasing attention. Cancer stem cells (CSCs) comprise ",

author = "M. Visweswaran and Frank Arfuso and Sudha Warrier and Arunasalam Dharmarajan",

year = "2020",

month = jan,

day = "1",

doi = "10.1002/stem.3101",

language = "English",

volume = "38",

pages = "6--14",

journal = "Stem Cells",

issn = "1066-5099",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells

AU - Visweswaran, M.

AU - Arfuso, Frank

AU - Warrier, Sudha

AU - Dharmarajan, Arunasalam

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Emerging evidence in cancer metabolomics has identified reprogrammed metabolic pathways to be a major hallmark of cancer, among which deregulated lipid metabolism is a prominent field receiving increasing attention. Cancer stem cells (CSCs) comprise

AB - Emerging evidence in cancer metabolomics has identified reprogrammed metabolic pathways to be a major hallmark of cancer, among which deregulated lipid metabolism is a prominent field receiving increasing attention. Cancer stem cells (CSCs) comprise

UR - https://www.scopus.com/pages/publications/85074868024

U2 - 10.1002/stem.3101

DO - 10.1002/stem.3101

M3 - Review article

SN - 1066-5099

VL - 38

SP - 6

EP - 14

JO - Stem Cells

JF - Stem Cells

IS - 1

ER -

Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this